Cargando…

Persistence of SARS-CoV-2-Specific Antibodies for 13 Months after Infection

Background: Dynamics of antibody responses were investigated after a SARS-CoV-2 outbreak in a private company during the first wave of the pandemic. Methods: Workers of a sewing company (Lithuania) with known SARS-CoV-2 RT-PCR result during the outbreak (April 2020) were invited to participate in th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kučinskaitė-Kodzė, Indrė, Simanavičius, Martynas, Šimaitis, Aistis, Žvirblienė, Aurelija
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8622371/ https://www.ncbi.nlm.nih.gov/pubmed/34835119 http://dx.doi.org/10.3390/v13112313

Ejemplares similares

Mapping of Recognition Sites of Monoclonal Antibodies Responsible for the Inhibition of Pneumolysin Functional Activity
por: Kucinskaite-Kodze, Indre, et al.
Publicado: (2020)

Electrochemical Determination of Interaction between SARS-CoV-2 Spike Protein and Specific Antibodies
por: Drobysh, Maryia, et al.
Publicado: (2022)

Investigation of SARS-CoV-2 nucleocapsid protein interaction with a specific antibody by combined spectroscopic ellipsometry and quartz crystal microbalance with dissipation
por: Plikusiene, Ieva, et al.
Publicado: (2022)

Construction of polyomavirus-derived pseudotype virus-like particles displaying a functionally active neutralizing antibody against hepatitis B virus surface antigen
por: Pleckaityte, Milda, et al.
Publicado: (2015)

The Use of Chimeric Virus-like Particles Harbouring a Segment of Hantavirus Gc Glycoprotein to Generate a Broadly-Reactive Hantavirus-Specific Monoclonal Antibody
por: Zvirbliene, Aurelija, et al.
Publicado: (2014)

Immunogenic Properties and Antigenic Similarity of Virus-like Particles Derived from Human Polyomaviruses
por: Lučiūnaitė, Asta, et al.
Publicado: (2023)

Evaluation of kinetics and thermodynamics of interaction between immobilized SARS-CoV-2 nucleoprotein and specific antibodies by total internal reflection ellipsometry
por: Plikusiene, Ieva, et al.
Publicado: (2021)

Evaluation of Trichodysplasia Spinulosa-Associated Polyomavirus Capsid Protein as a New Carrier for Construction of Chimeric Virus-Like Particles Harboring Foreign Epitopes
por: Gedvilaite, Alma, et al.
Publicado: (2015)

Characterization of a Panel of Cross-Reactive Hantavirus Nucleocapsid Protein-Specific Monoclonal Antibodies
por: Avižinienė, Aliona, et al.
Publicado: (2023)

Molecular characterization of invasive Neisseria meningitidis isolates collected in Lithuania (2009-2019) and estimation of serogroup B meningococcal vaccine 4CMenB and MenB-Fhbp coverage
por: Sereikaitė, Emilija, et al.
Publicado: (2023)

Activation of NLRP3 Inflammasome by Virus-Like Particles of Human Polyomaviruses in Macrophages
por: Lučiūnaitė, Asta, et al.
Publicado: (2022)

Selective immunocapture and light-controlled traceless release of transiently caged proteins
por: Rakauskaitė, Rasa, et al.
Publicado: (2021)

Characterization of the GBoV1 Capsid and Its Antibody Interactions
por: Yu, Jennifer Chun, et al.
Publicado: (2021)

Photocage-Selective Capture and Light-Controlled Release of Target Proteins
por: Rakauskaitė, Rasa, et al.
Publicado: (2020)

Production in yeast of pseudotype virus-like particles harboring functionally active antibody fragments neutralizing the cytolytic activity of vaginolysin
por: Pleckaityte, Milda, et al.
Publicado: (2011)

Activation of Macrophages by Oligomeric Proteins of Different Size and Origin
por: Dalgėdienė, Indrė, et al.
Publicado: (2018)

Generation of Recombinant Schmallenberg Virus Nucleocapsid Protein in Yeast and Development of Virus-Specific Monoclonal Antibodies
por: Lazutka, Justas, et al.
Publicado: (2014)

Robust neutralizing antibodies to SARS-CoV-2 infection persist for months
por: Wajnberg, Ania, et al.
Publicado: (2020)

Studies on Early Allergic Sensitization in the Lithuanian Birth Cohort
por: Dubakiene, Ruta, et al.
Publicado: (2012)

The Use of Recombinant Pseudotype Virus-Like Particles Harbouring Inserted Target Antigen to Generate Antibodies against Cellular Marker p16(INK4A)
por: Lasickienė, Rita, et al.
Publicado: (2012)

Neutralising SARS-CoV-2 RBD-specific antibodies persist for at least six months independently of symptoms in adults
por: Wagner, Angelika, et al.
Publicado: (2021)

Persistence of SARS-CoV-2-specific antibodies in COVID-19 patients
por: Wang, Yanan, et al.
Publicado: (2021)

6-month SARS-CoV-2 antibody persistency in a Tyrolian COVID-19 cohort
por: Deisenhammer, Florian, et al.
Publicado: (2020)

Persistence of SARS-CoV-2 antibodies beyond 6 months in health care workers in Mumbai
por: Singhal, Tanu, et al.
Publicado: (2021)

IgG SARS-CoV-2 Antibodies Persist at Least for 10 Months in Patients on Hemodialysis
por: Dudreuilh, Caroline, et al.
Publicado: (2021)

12-month SARS-CoV-2 antibody persistency in a Tyrolean COVID-19 cohort
por: Deisenhammer, Florian, et al.
Publicado: (2021)

Immunogenic properties of amyloid beta oligomers
por: Dalgediene, Indre, et al.
Publicado: (2013)

The antibody response to SARS-CoV-2 infection persists over at least 8 months in symptomatic patients
por: Levi, Riccardo, et al.
Publicado: (2021)

Persistence of SARS-CoV-2 neutralizing antibodies longer than 13 months in naturally infected, captive white-tailed deer (Odocoileus virginianus), Texas
por: Hamer, Sarah A., et al.
Publicado: (2022)

Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection
por: Gallais, Floriane, et al.
Publicado: (2021)

Investigation of markers of allergic sensitization and viral infections in children with allergy and asthma
por: Dubakienė, Rūta, et al.
Publicado: (2017)

Screening, Synthesis and Biochemical Characterization of SARS-CoV-2 Protease Inhibitors
por: Bagdonas, Martynas, et al.
Publicado: (2023)

Persistence of SARS-CoV-2–Specific IgG in Children 6 Months After Infection, Australia
por: Toh, Zheng Quan, et al.
Publicado: (2021)

Inhibitory Monoclonal Antibodies and Their Recombinant Derivatives Targeting Surface-Exposed Carbonic Anhydrase XII on Cancer Cells
por: Stravinskiene, Dovile, et al.
Publicado: (2020)

Generation of recombinant single-chain antibodies neutralizing the cytolytic activity of vaginolysin, the main virulence factor of Gardnerella vaginalis
por: Pleckaityte, Milda, et al.
Publicado: (2011)

Persistence of SARS-CoV-2 antibodies in kidney transplant recipients
por: Benotmane, Ilies, et al.
Publicado: (2021)

Neutralizing antibody response to SARS-CoV-2 persists 9 months post symptom onset in mild and asymptomatic patients
por: Bylicki, Olivier, et al.
Publicado: (2021)

SARS-CoV-2-specific CD4(+) T cells are associated with long-term persistence of neutralizing antibodies
por: Wang, Zhongfang, et al.
Publicado: (2022)

Antibodies to the Spike Protein Receptor-Binding Domain of SARS-CoV-2 at 4–13 Months after COVID-19
por: Kolosova, Evgeniia A., et al.
Publicado: (2022)

Generation of Recombinant Porcine Parvovirus Virus-Like Particles in Saccharomyces cerevisiae and Development of Virus-Specific Monoclonal Antibodies
por: Tamošiūnas, Paulius Lukas, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_rvegsf8aqplmge34eu5a0mcb6e